leisure time -WSS

leisure time

author：leisure time 2025-10-01 21:48:15 - browse：2456

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： House GOP plan to stem drug shortages differs from Democrats’

hotspot

explore

WSS

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

PBMs drew scrutiny in House hearing — and so did pharma

What happened to the House vote on health price transparency?

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Information blocking fines are now fair game in health care

Patients, doctors press FTC to beef up hospital merger scrutiny

hotspot

leisure time

entertainment

Psychedelics group wrestles with new pharma identity

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Medicare details structure of new drug price negotiation program

FDA panel to weigh safety of artificial wombs for preterm births

Medicare details structure of new drug price negotiation program

Information blocking fines are now fair game in health care

Tori Bowie and the unacceptable rates of Black maternal death

What AstraZeneca

The high cost of giving birth even with insurance

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

focus

'Weather

Neurocrine congenital adrenal hyperplasia trial succeeds

Akili changes sales model for its ADHD video game treatment

People with substance use disorder deserve online privacy

FDA weighs limits of animal data in assessing artificial wombs

Judge orders hearing on Trump's motion to disqualify Fulton County DA

hotspot

hotspot

explore

explore